Miami, FL – (November 29, 2009) – Modern Veterinary Therapeutics, LLC announces today that the Veterinary Drugs Directorate (VDD) has approved REVERTOR in Canada. REVERTOR is indicated for the reversal of the clinical effects of the sedative and analgesic agent, medetomidine hydrochloride, in dogs. The product will be presented in 10 mL vial.

“Modern Veterinary Therapeutics LLC is pleased to begin offering this product which represents our third approval within a month and our fifth approval in less than a year in Canada. This track of records speaks for itself about the technical and regulatory expertise of our young company and demonstrates one more time our commitment to serve Veterinarians in Canada”, said Dr Cuong Tu Ba, Founder and President of Modern Veterinary Therapeutics, LLC.